Live Breaking News & Updates on கல்லூரி மருத்துவ இமேஜிங்

Stay updated with breaking news from கல்லூரி மருத்துவ இமேஜிங். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Recycle anaesthetics to reduce carbon emission of healthcare, study concludes


New research has highlighted the value of recycling general anaesthetic used in routine operations.
In the UK, healthcare accounts for more than five per cent of national greenhouse gas emissions, and as much as 10 per cent in the US. Inhaled general anaesthetics are particularly potent greenhouse gases and as little is metabolised almost all that is administered is breathed out to end up in the atmosphere. The commonly used anaesthetic agents have been considered to vary considerably from as little as 1.5 for sevoflurane to more than 60 kg carbon dioxide equivalence for an hour s anaesthetic with desflurane. However, research led by a team from the University of Exeter have discovered that the original assumptions failed to consider the manufacture of the anaesthetics, questioning the validity of the initial assumptions and the subsequent conclusions. ....

United Kingdom , Jodi Shearman , Louise Vennells , University Of Exeter Medical School Medicine , College Medical Imaging , University Of Exeter Medical School , University Of Exeter , Times Good University , Russell Group , University Of Exeter College Medicine , Health Sciences , Innovate United Kingdom , Exeter Medical School , Exeter Medical , South West , Sunday Times Good University Guide , Complete University Guide , Medical Imaging , Guardian Guide , Media Manager , Medicine Health , Health Professionals , Pharmaceutical Science , Public Health , Climate Change , ஒன்றுபட்டது கிஂக்டம் ,

New drug molecules hold promise for treating fatal child disease


 E-Mail
Scientists have identified a way to rescue muscle cells that have genetically mutated, paving the way to a possible new treatment for rare childhood illness such as Duchenne Muscular Dystrophy (DMD).
The study, led by the Universities of Exeter and Nottingham, is published in the
Proceedings of the National Academies of Sciences, USA. The research used novel drugs being developed at the University of Exeter, which metabolically reprogram the cellular energy production centres in muscle cells, by providing them with a fuel source to generate metabolic energy.
DMD is a genetic condition caused by a mutation in a gene called dystrophin which results in progressive irreversible muscular degeneration and weakening. Its symptoms include muscle atrophy leading to a loss of the ability to walk in children for which there is no known cure. Currently, the condition is treated with steroids, such as prednisone, but they can stop working and side-effects are com ....

United States , United Kingdom , Jon Rees , Rebecca Ellwood , Nate Szewczyk , Kate Adcock , Louise Vennells , Matt Whiteman , United Mitochondrial Disease Foundation , Contact Mitorx , University Of Exeter Medical School Medicine , College Medical Imaging , University Of Exeter Medical School , Research Council United Kingdom , Times Good University , University Of Exeter , Health Sciences , Ohio Musculoskeletal Neurological Institute , Russell Group , University Of Exeter College Medicine , Proceedings Of The National Academies Sciences , Duchenne Muscular Dystrophy , National Academies , Medical Research Council , Professors Nate Szewczyk , Ohio Musculoskeletal ,